Fresh attention on Charles Schwab (SCHW) comes after Linqto’s ongoing litigation against Forge Global and Schwab, as well as Schwab’s recent multibillion-dollar fixed income offerings, prompting investors to reassess the stock’s risk profile and funding mix.

At a share price of $111.68, Charles Schwab has seen a 23.94% 90 day share price return and an 18.12% 1 year total shareholder return. This suggests momentum has been building as investors weigh the Linqto litigation alongside fresh fixed income issuance and product launches in futures and long short strategies.

If this kind of activity has you thinking more broadly about where capital is moving, it can be worth scanning other areas of the market through our 21 top founder-led companies

Charles Schwab now trades about 12% below both analyst targets and an estimated fair value, even after a strong run. Is that a simple valuation gap, or is the market applying a justified discount for litigation and funding risks?

Most Popular Narrative: 10% Overvalued

The most followed narrative pegs Charles Schwab’s fair value at about $101, below the recent $111.68 share price, and builds that view around detailed revenue, margin and risk assumptions.

Heavy investment in AI, technology and new platforms such as spot crypto could overshoot sustainable demand. This may lead to structurally higher run-rate technology and personnel spending that compresses operating leverage and erodes pretax margins, even if revenues keep growing.

Want to see why this narrative still expects higher earnings yet lands on a lower fair value? The story blends rising revenue, shifting margins and a trimmed future earnings multiple into one tight valuation case.

Result: Fair Value of $101.12 (OVERVALUED)

However, the narrative could still be challenged if younger, highly engaged clients keep building long term relationships with Charles Schwab and if higher value advisory flows continue to grow.

Another View on Charles Schwab’s Valuation

The first narrative leans on analyst targets and long term earnings assumptions, and lands on Charles Schwab looking about 10% overvalued at a fair value of roughly $101 per share. Using our DCF model tells a different story. On that measure, the stock screens as undervalued at around $126.90. Which framework do you think better reflects how Schwab’s cash flows might evolve over time?

Next Steps

With mixed sentiment around Charles Schwab’s valuation, litigation exposure and funding choices, now is a good time to review the underlying data yourself and decide what matters most. To balance the concerns against the potential upside, start with the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Charles Schwab?

If you want a broader view of where your next opportunity might come from, use the Simply Wall St screener to compare Charles Schwab with other potential candidates.

• Target potential mispriced opportunities by reviewing 50 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their profiles.
• Strengthen the income side of your portfolio by scanning 11 dividend fortresses that currently offer higher yields with detailed payout data.
• Lower overall portfolio risk by assessing 79 resilient stocks with low risk scores that our model scores as more resilient on key financial and volatility measures.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.